DERM (Journey Medical) Price-to-Operating-Cash-Flow : (As of Jun. 25, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Journey Medical Price-to-Operating-Cash-Flow?

As of today (2025-06-25), Journey Medical's share price is $6.895. Journey Medical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.34. Hence, Journey Medical's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Journey Medical's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 6 years, Journey Medical's highest Price-to-Operating-Cash-Flow Ratio was 84.82. The lowest was 3.44. And the median was 8.40.

DERM's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.58
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Journey Medical's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $-0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.34.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -27.80% per year.

During the past 6 years, Journey Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was -20.00% per year. The lowest was -27.80% per year. And the median was -23.90% per year.

Journey Medical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Journey Medical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Journey Medical Price-to-Operating-Cash-Flow Chart

Journey Medical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

20.07

Journey Medical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Journey Medical's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Journey Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Journey Medical's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Journey Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Journey Medical's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Journey Medical Price-to-Operating-Cash-Flow Calculation

Journey Medical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	6.895	/	-0.336
	=

Journey Medical's Share Price of today is $6.895.
Journey Medical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Journey Medical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Journey Medical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Journey Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Journey Medical Corp (NAS:DERM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

9237 E Via de Ventura Boulevard, Suite 105, Scottsdale, AZ, USA, 85258

Website

https://www.journeymedicalcorp.com

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Executives

Joseph Benesch	officer: Interim CFO	C/O TELIGENT, 105 LINCOLN AVENUE, BUENA NJ 08310
Claude Maraoui	director, officer: President & CEO	C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE AZ 85258
Rosenwald Lindsay A Md	director	375 PARK AVE, NEW YORK NY 10152
Justin Adam Smith	director	C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE AZ 85258
Jeffrey Paley	director	C/O RETROPHIN INC., 777 THIRD AVENUE, 22ND FLOOR, NEW YORK NY 10017
De Paolantonio Ernest Robert	officer: Chief Financial Officer	4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC 27612
Neil Herskowitz	director	2109 BROADWAY, SUITE 206, NEW YORK NY 10023
Miranda Jayne Toledano	director	C/O COMPASS THERAPEUTICS, INC., 80 GUEST STREET, SUITE 601, BOSTON MA 02135